| Literature DB >> 36056357 |
Yunfei Wu1, Junhua Zhang2, Xiang Li2, Nanbo Liu2, Jun Li2, Xuyuan Chen2, Lichun Wei2.
Abstract
BACKGROUND: Patients with locally advanced esophageal cancer with a lesion length greater than 8 cm (LCWEC) are prone to high mortality in a short time due to esophagotracheal fistula (ETF) and esophagoaortic fistula (EAF). We tried to explore a safe salvage surgical method during the perioperative period to maximize the resection of the tumor on the premise of safety and reconstruction of the alimentary tract to avoid early death due to ETF and EAF.Entities:
Keywords: Esophageal cancer; Esophagogastric fistula; Length; Locally advanced esophageal cancer esophagotracheal fistula; Modified (Wu’s) esophagectomy
Mesh:
Year: 2022 PMID: 36056357 PMCID: PMC9438225 DOI: 10.1186/s13019-022-01942-3
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.522
Fig. 1Imaging manifestations of LCWEC. PET showing the initial invasion of the esophageal cancer tumor of the tracheal membrane and the aorta, with almost complete obstruction of the esophagus and compression of the trachea, without tumor metastasis in important systemic organs, with or without tumor metastasis of supraclavicular and abdominal lymph nodes
Fig. 2Preoperative upper gastrointestinal radiography manifestations of LCWEC. Preoperative upper gastrointestinal radiography displayed the filling defects caused by esophageal cancer in images A, B and C, which were 22.5 cm, 12.6 cm, and 18.3 cm, respectively, with almost complete obstruction of the esophagus
Patient characteristics
| All number (n = 45) (%) | |
|---|---|
| Age (years), mean (range) | 59.6 (42–78) |
| Sex (M/F) | |
| Male | 32 (71.1%) |
| Female | 13 (28.9%) |
| Body mass index (BMI), mean ± SD | 19.15 ± 2.38 |
| Blood routine test | |
| Hemoglobin (g/L), mean ± SD | 118.8 ± 26.64 |
| Albumin (g/L), mean ± SD | 33.1 ± 1.9 |
| History of smoking | 35 (77.7%) |
| History of alcohol | 28(62.2%) |
| Prior gastric or esophageal surgery | 0 (3.2%) |
| Previous chest surgery | 1 (1.6%) |
| Comorbidities | |
| Coronary artery disease | 3 (6.0%) |
| Diabetes mellitus | 11 (24.4%) |
| COPD/emphysema | 4 (8.8%) |
| Location of lesion | |
| Upper thoracic esophagus | 10 (22.2%) |
| Middle thoracic esophagus | 30 (66.7%) |
| Lower thoracic esophagus | 5 (11.1%) |
Pathologic outcomes
| All (n = 45) (%) | |
|---|---|
| Tumor length (cm), mean ± SD | 12.5 ± 5.0 |
| Maximum transverse | |
| Diameter of tumor (cm), mean ± SD | 5.8 (range 4.5–7.8) |
| Depth of tumor invasion | |
| pTis | 0 |
| pT1 | 0 |
| pT2 | 0 |
| pT3 | 5 (11.1%) |
| pT4a | 37 (82.2%) |
| pT4b | 3 (6.7%) |
| Lymph node metastasis | |
| pN0 | 0 |
| pN1 | 11 (24.4%) |
| pN2 | 16 (35.6%) |
| pN3 | 18 (40.0%) |
| M1(supraclavicular lymph nodes) | 11 (24.4%) |
| Pathologic stage | |
| 0 | 0 |
| 1 | 0 |
| 2A | 0 |
| 2B | 0 |
| IIIB | 19 (42.2%) |
| IVA | 5 (11.1%) |
| IVB | 21 (46.7%) |
| Differentiation | |
| G1 | 15 (33.3%) |
| G2 | 30 (66.7%) |
| G3 | 0 |
| Gx | 0 |
| R0 resection | 8 (17.7%) |
| Positive CRM | 37 (82.2%) |
| Cutting edge of positive anastomosis | 0 |
Intraoperative characteristics and surgical
| Variables | |
|---|---|
| Operation time (min) | 583 (range 286–1075) |
| blood loss (ml), mean ± SD | 375 ± 104 |
| Preoperative blood transfusion, n (%) | 6 (13) |
| Intraoperative blood transfusion, n (%) | 33(74) |
| Postoperative blood transfusion, n (%) | 6 (13) |
| Number of harvested lymph | 28.2 (8.6) |
| Nodes, Mean ± SD | |
| Thoracic | 19.1 ± 6.4 |
| Abdominal | 6.5 ± 3.3 |
| Supraclavicular | 2.6 ± 1.2 |
| Width of the anastomotic orifice (mm) | 21.7 ± 2.2 |
| Overall complications, n (%) | 4 (8) |
| Surgical complications, n (%) | |
| Anastomotic leakagea | 0 |
| Chylothoraxb | 0 |
| Vocal Cord Injury/Palsyc | 0 |
| Delayed gastric emptying α | 0 |
| Anastomotic stenosis β | 0 |
| Regurgitationd | 0 |
| Wound infectione | 0 |
| Necrosis of gastric tubeθ | 0 |
| Non-surgical complications, n (%) | |
| Pneumoniaf | 3 (6.0) |
| Atrial fibrillationg | 1 (2.0) |
| Reoperation within 30 days | 0 |
| In-hospital/Mortality within 30 days | 0 |
| Postoperative length of stay (days), mean (SD) | 17.5 (5.3) |
| Reintubation | 0 |
| (Death) DVT/pulmonary embolism | 0 |
aECCG, Type I–III; bECCG, Type I–IIII; cType I–III; αCD, Grade I–II; βCD, Grade; dCD, Grade I; θ CD, Grade I; eCD, Grade I; fCD, Grade II–III; gCD, Grade III
Fig. 3Postoperative upper gastrointestinal radiography manifestations of LCWEC. Postoperative upper gastrointestinal radiography illustrating that the gastric emptying was unobstructed
Fig. 4Kaplan–Meier survival estimates of multimodal treatment versus surgery for LCWEC patients
Pathological staging and follow-up of patients treated with either postoperative multimodal treatment or surgery alone
| Multimodal (n = 29) | Surgery (n = 16) | ||
|---|---|---|---|
| R0 Resection | 5 (17.2) | 3(18.7) | > 0.05 |
| Positive CRM | 24 (82.7) | 13(81.2) | > 0.05 |
| Pstage IIIB–IVB | 29 (100.0) | 16 (100.0) | > 0.05 |
| Survival, median (range) | 32 (0–98) | 19.15 ± 2.38 | < 0.001 |